ProShare Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $107K | Sell |
30,474
-5,841
| -16% | -$23.9K | ﹤0.01% | 1694 |
|
|
2025
Q4 | $122K | Buy |
36,315
+3,170
| +10% | +$8.23K | ﹤0.01% | 1833 |
|
|
2025
Q3 | $43.4K | Sell |
33,145
-5,707
| -15% | -$5.91K | ﹤0.01% | 1946 |
|
|
2025
Q2 | $27.9K | Buy |
38,852
+1,007
| +3% | +$791 | ﹤0.01% | 2048 |
|
|
2025
Q1 | $55.6K | Sell |
37,845
-12,359
| -25% | -$29.4K | ﹤0.01% | 1940 |
|
|
2024
Q4 | $222K | Buy |
50,204
+11,267
| +29% | +$45.7K | ﹤0.01% | 1830 |
|
|
2024
Q3 | $160K | Buy |
38,937
+7,764
| +25% | +$41.7K | ﹤0.01% | 1787 |
|
|
2024
Q2 | $203K | Sell |
31,173
-7,710
| -20% | -$54.5K | ﹤0.01% | 1523 |
|
|
2024
Q1 | $339K | Buy |
38,883
+2,917
| +8% | +$35.4K | ﹤0.01% | 1353 |
|
|
2023
Q4 | $411K | Buy |
35,966
+4,703
| +15% | +$46.5K | ﹤0.01% | 1164 |
|
|
2023
Q3 | $301K | Sell |
31,263
-348
| -1% | -$3.41K | ﹤0.01% | 1206 |
|
|
2023
Q2 | $336K | Buy |
31,611
+1,195
| +4% | +$12.8K | ﹤0.01% | 1198 |
|
|
2023
Q1 | $320K | Sell |
30,416
-3,750
| -11% | -$42K | ﹤0.01% | 1176 |
|
|
2022
Q4 | $423K | Buy |
34,166
+2,580
| +8% | +$29.3K | ﹤0.01% | 1042 |
|
|
2022
Q3 | $328K | Sell |
31,586
-162
| -0.5% | -$1.84K | ﹤0.01% | 1095 |
|
|
2022
Q2 | $367K | Sell |
31,748
-12,258
| -28% | -$144K | ﹤0.01% | 1093 |
|
|
2022
Q1 | $553K | Sell |
44,006
-11,105
| -20% | -$127K | ﹤0.01% | 1221 |
|
|
2021
Q4 | $642K | Buy |
55,111
+1,692
| +3% | +$20.8K | ﹤0.01% | 1292 |
|
|
2021
Q3 | $698K | Sell |
53,419
-13,372
| -20% | -$173K | ﹤0.01% | 1031 |
|
|
2021
Q2 | $860K | Buy |
66,791
+1,875
| +3% | +$21.5K | ﹤0.01% | 1121 |
|
|
2021
Q1 | $726K | Buy |
64,916
+4,855
| +8% | +$51.3K | ﹤0.01% | 1188 |
|
|
2020
Q4 | $684K | Buy |
60,061
+14,732
| +33% | +$161K | ﹤0.01% | 1077 |
|
|
2020
Q3 | $408K | Sell |
45,329
-1,825
| -4% | -$18.1K | ﹤0.01% | 1024 |
|
|
2020
Q2 | $487K | Buy |
47,154
+16,428
| +53% | +$168K | ﹤0.01% | 958 |
|
|
2020
Q1 | $310K | Sell |
30,726
-24,021
| -44% | -$282K | ﹤0.01% | 864 |
|
|
2019
Q4 | $729K | Sell |
54,747
-5,122
| -9% | -$56.5K | ﹤0.01% | 915 |
|
|
2019
Q3 | $514K | Sell |
59,869
-459
| -0.8% | -$4.46K | ﹤0.01% | 977 |
|
|
2019
Q2 | $660K | Sell |
60,328
-20,661
| -26% | -$231K | ﹤0.01% | 910 |
|
|
2019
Q1 | $918K | Buy |
80,989
+6,637
| +9% | +$74.1K | 0.01% | 799 |
|
|
2018
Q4 | $645K | Sell |
74,352
-13,651
| -16% | -$157K | ﹤0.01% | 858 |
|
|
2018
Q3 | $1.36M | Sell |
88,003
-3,000
| -3% | -$47.4K | 0.01% | 698 |
|
|
2018
Q2 | $1.46M | Sell |
91,003
-5,127
| -5% | -$75.9K | 0.01% | 697 |
|
|
2018
Q1 | $1.24M | Sell |
96,130
-14,836
| -13% | -$185K | 0.01% | 753 |
|
|
2017
Q4 | $1.39M | Buy |
110,966
+9,082
| +9% | +$119K | 0.01% | 722 |
|
|
2017
Q3 | $1.35M | Buy |
101,884
+5,510
| +6% | +$75.8K | 0.01% | 660 |
|
|
2017
Q2 | $1.52M | Sell |
96,374
-6,174
| -6% | -$89.7K | 0.02% | 626 |
|
|
2017
Q1 | $1.47M | Sell |
102,548
-25,726
| -20% | -$352K | 0.02% | 645 |
|
|
2016
Q4 | $1.64M | Buy |
128,274
+13,149
| +11% | +$166K | 0.02% | 611 |
|
|
2016
Q3 | $1.53M | Sell |
115,125
-17,963
| -13% | -$210K | 0.02% | 565 |
|
|
2016
Q2 | $1.46M | Buy |
133,088
+2,043
| +2% | +$20K | 0.02% | 611 |
|
|
2016
Q1 | $1.2M | Sell |
131,045
-12,777
| -9% | -$105K | 0.02% | 641 |
|
|
2015
Q4 | $1.4M | Buy |
143,822
+14,119
| +11% | +$136K | 0.02% | 624 |
|
|
2015
Q3 | $1.13M | Sell |
129,703
-9,424
| -7% | -$87.9K | 0.02% | 640 |
|
|
2015
Q2 | $1.41M | Sell |
139,127
-8,936
| -6% | -$104K | 0.02% | 631 |
|
|
2015
Q1 | $1.98M | Buy |
148,063
+19,615
| +15% | +$257K | 0.02% | 564 |
|
|
2014
Q4 | $1.65M | Sell |
128,448
-2,586
| -2% | -$29.6K | 0.02% | 634 |
|
|
2014
Q3 | $1.42M | Sell |
131,034
-25,123
| -16% | -$288K | 0.02% | 914 |
|
|
2014
Q2 | $2M | Sell |
156,157
-79,239
| -34% | -$862K | 0.03% | 746 |
|
|
2014
Q1 | $2.43M | Buy |
235,396
+176,041
| +297% | +$1.98M | 0.03% | 633 |
|
|
2013
Q4 | $577K | Sell |
59,355
-50,801
| -46% | -$456K | 0.01% | 1054 |
|
|
2013
Q3 | $1.09M | Buy |
110,156
+23,969
| +28% | +$235K | 0.03% | 805 |
|
|
2013
Q2 | $718K | Buy |
+86,187
| New | +$1.04M | 0.01% | 1063 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
ProShare Advisors's IRWD Position: Q1 2026 in Review
ProShare Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 16% in Q1 2026, selling an estimated $23.9K and leaving 30,474 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #1694.
ProShare Advisors first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.43M in Q1 2014. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- ProShare Advisors held 30,474 shares of Ironwood Pharmaceuticals worth $107K as of Q1 2026.
- ProShare Advisors sold 5,841 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $23.9K.
- Ironwood Pharmaceuticals made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1694 holding.
- ProShare Advisors first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Ironwood Pharmaceuticals position peaked at $2.43M in Q1 2014.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.